Cargando…
mRNA Delivery Platform Based on Bacterial Outer Membrane Vesicles for Tumor Vaccine
The rapid display and delivery method for customized tumor mRNA vaccines is limited. Herein, bacteria-derived outer membrane vesicles (OMVs) are employed as an mRNA delivery platform by surface engineering of an RNA-binding protein, L7Ae. OMV-L7Ae can rapidly adsorb boxC/D sequence-labeled mRNA anti...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bio-Protocol
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338712/ https://www.ncbi.nlm.nih.gov/pubmed/37456344 http://dx.doi.org/10.21769/BioProtoc.4774 |
_version_ | 1785071684936531968 |
---|---|
author | Gao, Xiaoyu Li, Yao Nie, Guangjun Zhao, Xiao |
author_facet | Gao, Xiaoyu Li, Yao Nie, Guangjun Zhao, Xiao |
author_sort | Gao, Xiaoyu |
collection | PubMed |
description | The rapid display and delivery method for customized tumor mRNA vaccines is limited. Herein, bacteria-derived outer membrane vesicles (OMVs) are employed as an mRNA delivery platform by surface engineering of an RNA-binding protein, L7Ae. OMV-L7Ae can rapidly adsorb boxC/D sequence-labeled mRNA antigens through L7Ae-boxC/D binding and deliver them into HEK-293T and dendritic cells. This platform provides an mRNA delivery technology distinct from lipid nanoparticles (LNPs) for personalized mRNA tumor vaccination and with a Plug-and-Display strategy suitable for rapid preparation of the personalized mRNA tumor vaccine against varied tumor antigens. Key features OMVs are employed as an mRNA delivery platform through L7Ae-boxC/D binding. |
format | Online Article Text |
id | pubmed-10338712 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Bio-Protocol |
record_format | MEDLINE/PubMed |
spelling | pubmed-103387122023-07-14 mRNA Delivery Platform Based on Bacterial Outer Membrane Vesicles for Tumor Vaccine Gao, Xiaoyu Li, Yao Nie, Guangjun Zhao, Xiao Bio Protoc Methods Article The rapid display and delivery method for customized tumor mRNA vaccines is limited. Herein, bacteria-derived outer membrane vesicles (OMVs) are employed as an mRNA delivery platform by surface engineering of an RNA-binding protein, L7Ae. OMV-L7Ae can rapidly adsorb boxC/D sequence-labeled mRNA antigens through L7Ae-boxC/D binding and deliver them into HEK-293T and dendritic cells. This platform provides an mRNA delivery technology distinct from lipid nanoparticles (LNPs) for personalized mRNA tumor vaccination and with a Plug-and-Display strategy suitable for rapid preparation of the personalized mRNA tumor vaccine against varied tumor antigens. Key features OMVs are employed as an mRNA delivery platform through L7Ae-boxC/D binding. Bio-Protocol 2023-07-05 /pmc/articles/PMC10338712/ /pubmed/37456344 http://dx.doi.org/10.21769/BioProtoc.4774 Text en ©Copyright : © 2023 The Authors; This is an open access article under the CC BY license https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Methods Article Gao, Xiaoyu Li, Yao Nie, Guangjun Zhao, Xiao mRNA Delivery Platform Based on Bacterial Outer Membrane Vesicles for Tumor Vaccine |
title | mRNA Delivery Platform Based on Bacterial Outer Membrane Vesicles for Tumor Vaccine |
title_full | mRNA Delivery Platform Based on Bacterial Outer Membrane Vesicles for Tumor Vaccine |
title_fullStr | mRNA Delivery Platform Based on Bacterial Outer Membrane Vesicles for Tumor Vaccine |
title_full_unstemmed | mRNA Delivery Platform Based on Bacterial Outer Membrane Vesicles for Tumor Vaccine |
title_short | mRNA Delivery Platform Based on Bacterial Outer Membrane Vesicles for Tumor Vaccine |
title_sort | mrna delivery platform based on bacterial outer membrane vesicles for tumor vaccine |
topic | Methods Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338712/ https://www.ncbi.nlm.nih.gov/pubmed/37456344 http://dx.doi.org/10.21769/BioProtoc.4774 |
work_keys_str_mv | AT gaoxiaoyu mrnadeliveryplatformbasedonbacterialoutermembranevesiclesfortumorvaccine AT liyao mrnadeliveryplatformbasedonbacterialoutermembranevesiclesfortumorvaccine AT nieguangjun mrnadeliveryplatformbasedonbacterialoutermembranevesiclesfortumorvaccine AT zhaoxiao mrnadeliveryplatformbasedonbacterialoutermembranevesiclesfortumorvaccine |